GLP-1 medicines (Glucagon-Like Peptide-1 receptor agonists) are a class of drugs used to manage Type 2 diabetes and, increasingly, obesity and weight-related metabolic conditions
Vascular disruption is associated with cognitive decline in degenerative diseases, including Alzheimer's disease (AD) (Zlokovic, 2011), Parkinson's disease (PD) (Malek et al., 2016), Huntington's disease (HD) (Lin et al., 2013), and amyotrophic lateral sclerosis (ALS) (Winkler et al., 2013)
Diet and risk of colorectal cancer in a cohort of Finnish men
These effects can be particularly beneficial for individuals with heart conditions or those looking to improve their cardiovascular health
Frequently asked questions about spironolactone What are some health benefits of spironolactone
For EU customs and B2B trade rules, see the European Commission Taxation and Customs Union portal